Targeted biomimetic hollow mesoporous organosilica nanoparticles for delivery of doxorubicin to colon adenocarcinoma: In vitro and in vivo evaluation

Jemal, 2011, Global cancer statistics, Cancer J. Clin, 61, 69, 10.3322/caac.20107 Bray, 2013, Global estimates of cancer prevalence for 27 sites in the adult population in 2008, Int. J. Cancer, 132, 1133, 10.1002/ijc.27711 Jaferian, 2016, Colon cancer targeting using conjugates biomaterial 5-flurouracil, Biomed, Pharma, 84, 780 Siegel, 2020, Colorectal cancer statistics, 2020, CA, Cancer J. Clin, 70, 145, 10.3322/caac.21601 Ewer, 2015, Cardiotoxicity of anticancer treatments, Nat. Rev. Cardiol., 12, 547, 10.1038/nrcardio.2015.65 Cheng, 2012, Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities, Science, 338, 903, 10.1126/science.1226338 Alibolandi, 2017, Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo, Int. J. Pharm., 532, 581, 10.1016/j.ijpharm.2017.09.039 Chakravarty, 2015, Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery, Nanomedicine, 10, 1233, 10.2217/nnm.14.226 Shi, 2013, On the synergetic catalytic effect in heterogeneous nanocomposite catalysts, Chem. Rev, 113, 2139, 10.1021/cr3002752 Zahiri, 2020, Hybrid nanoreservoirs based on dextran‐capped dendritic mesoporous silica nanoparticles for CD133‐targeted drug delivery, J. Cell. Physiol, 235, 1036, 10.1002/jcp.29019 Akbarzadeh, 2019, Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system, Int. J. Pharm., 570, 118645, 10.1016/j.ijpharm.2019.118645 Babaei, 2017, Synthesis of theranostic epithelial cell adhesion molecule targeted mesoporous silica nanoparticle with gold gatekeeper for hepatocellular carcinoma, Nanomedicine, 12, 1261, 10.2217/nnm-2017-0028 Zhang, 2015, Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery, ACS Appl. Mater. Interfaces, 7, 18179, 10.1021/acsami.5b05893 Luo, 2014, Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity, Biomaterials, 35, 7951, 10.1016/j.biomaterials.2014.05.058 Lee, 2011, Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications, Acc. Chem. Res, 44, 893, 10.1021/ar2000259 Chen, 2019, Mesoporous silica nanoparticles for tissue‐engineering applications, Wiley Interdisciplinary Rev. Nanomed. Nanobiotechnol, 11, e1573, 10.1002/wnan.1573 Manzano, 2020, Mesoporous silica nanoparticles for drug delivery, Adv. Funct. Mater., 30, 1902634, 10.1002/adfm.201902634 Lei, 2019, Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy, Mater. Sci. Eng. C, 105, 110103, 10.1016/j.msec.2019.110103 Wang, 2021, Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy, J. Contr. Release, 339, 445, 10.1016/j.jconrel.2021.10.005 Lin, 2012, Critical considerations in the biomedical use of mesoporous silica nanoparticles, J. Phys. Chem. Lett, 3, 364, 10.1021/jz2013837 Rosenholm, 2012, Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage, Nanomedicine, 7, 111, 10.2217/nnm.11.166 García‐Fernández, 2020, New advances in in vivo applications of gated mesoporous silica as drug delivery nanocarriers, Small, 16, 1902242, 10.1002/smll.201902242 Liu, 2016, Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy, Biomaterials, 83, 51, 10.1016/j.biomaterials.2016.01.008 Luo, 2013, Engineering a hollow nanocontainer platform with multifunctional molecular machines for tumor-targeted therapy in vitro and in vivo, ACS Nano, 7, 10271, 10.1021/nn404676w Ma, 2012, Ultrasmall sub-10 nm near-infrared fluorescent mesoporous silica nanoparticles, J. Am. Chem. Soc, 134, 13180, 10.1021/ja3049783 Croissant, 2018, Mesoporous silica and organosilica nanoparticles: physical chemistry, biosafety, delivery strategies, and biomedical applications, Adv. Healthc. Mater, 7, 1700831, 10.1002/adhm.201700831 Yang, 2019, Mesoporous silica/organosilica nanoparticles: synthesis, biological effect and biomedical application, Mater. Sci. Eng. R Rep, 137, 66, 10.1016/j.mser.2019.01.001 Tao, 2021, Intricately structured mesoporous organosilica nanoparticles: synthesis strategies and biomedical applications, Biomater Sci, 9, 1609, 10.1039/D0BM02157A Du, 2016, Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery, Biomaterials, 91, 90, 10.1016/j.biomaterials.2016.03.019 M. Zhou, X. Du, W. Li, X. Li, H. Huang, Q. Liao, B. Shi, X. Zhanga, M. Zhang, One-pot Synthesis of Redox-Triggered Biodegradable Hybrid Nanocapsules with Disulfide. Croissant, 2016 He, 2017, Synthesis of pH-responsive biodegradable mesoporous silica–calcium phosphate hybrid nanoparticles as a high potential drug carrier, ACS Appl. Mater. Interfaces, 9, 44402, 10.1021/acsami.7b16787 Du, 2018, Disulfide‐bridged organosilica frameworks: designed, synthesis, redox‐triggered biodegradation, and nanobiomedical applications, Adv. Funct. Mater, 28, 1707325, 10.1002/adfm.201707325 Hadipour Moghaddam, 2017, Redox-responsive polysulfide-based biodegradable organosilica nanoparticles for delivery of bioactive agents, ACS Appl. Mater. Interfaces, 9, 21133, 10.1021/acsami.7b04351 Fan, 2020, Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery, J. Nanobiotechnol., 18, 1, 10.1186/s12951-020-00642-1 Qian, 2014, Organic-inorganic hybrid hollow mesoporous organosilica nanoparticles for efficient ultrasound-based imaging and controlled drug release, J. Nanomater, 2014 Nguyen, 2020, Aminated hollow mesoporous silica nanoparticles as an enhanced loading and sustained releasing carrier for doxorubicin delivery, Microporous Mesoporous Mater, 309, 110543, 10.1016/j.micromeso.2020.110543 Fang, 2014, Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, Nano Lett, 14, 2181, 10.1021/nl500618u Xie, 2019, Oriented assembly of cell-mimicking nanoparticles via a molecular affinity strategy for targeted drug delivery, ACS Nano, 13, 5268, 10.1021/acsnano.8b09681 Rao, 2017, Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy, ACS Nano, 11, 3496, 10.1021/acsnano.7b00133 Jiang, 2017, Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy, Biomaterials, 143, 29, 10.1016/j.biomaterials.2017.07.027 Shen, 2014, iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance, Mol. Pharm, 11, 2579, 10.1021/mp400576f Zavvar, 2020, Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model, Int. J. Pharm., 578, 119091, 10.1016/j.ijpharm.2020.119091 Alibolandi, 2018, CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer, Artif Cells Nanomed Biotechnol, 46, 1159, 10.1080/21691401.2018.1446969 Sanati, 2021, Fabrication of anionic dextran-coated micelles for aptamer targeted delivery of camptothecin and survivin-shRNA to colon adenocarcinoma, Gene Ther., 1 Jalalian, 2013, Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo, Eur. J. Pharmaceut. Sci., 50, 191, 10.1016/j.ejps.2013.06.015 Pascual, 2017, MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications, Nanomedicine, 13, 2495, 10.1016/j.nano.2017.08.006 Charbgoo, 2018, MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide, Nanomedicine, 14, 685, 10.1016/j.nano.2017.12.010 Nabavinia, 2017, Anti‐MUC1 aptamer: a potential opportunity for cancer treatment, Med. Res. Rev, 37, 1518, 10.1002/med.21462 Rao, 2015, Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance, Small, 11, 6225, 10.1002/smll.201502388 Araste, 2020, Na+/K+ ATPase-targeted delivery to metastatic breast cancer models, Eur. J. Pharmaceut. Sci., 143, 105207, 10.1016/j.ejps.2019.105207 Shahriari, 2019, Synthesis of hyaluronic acid-based polymersomes for doxorubicin delivery to metastatic breast cancer, Int. J. Pharm., 572, 118835, 10.1016/j.ijpharm.2019.118835 Hao, 2015, One-step synthesis of amine-functionalized hollow mesoporous silica nanoparticles as efficient antibacterial and anticancer materials, ACS Appl. Mater, 7, 1040, 10.1021/am508219g She, 2015, 2015 Kong, 2017, Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency, Theranostics, 7, 3276, 10.7150/thno.19987 Su, 2019, Facile synthesis of monodisperse hollow mesoporous organosilica/silica nanospheres by an in situ dissolution and reassembly approach, ACS Appl. Mater. Interfaces, 11, 12063, 10.1021/acsami.8b21906 Babaei, 2020, Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo, Eur. J. Pharm. Biopharm, 156, 84, 10.1016/j.ejpb.2020.08.026 Nejabat, 2018, Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma, Carbohydr. Polym, 197, 157, 10.1016/j.carbpol.2018.05.092 Bagheri, 2018, Silica based hybrid materials for drug delivery and bioimaging, J. Contr. Release, 277, 57, 10.1016/j.jconrel.2018.03.014 Chen, 2014, Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine, J. Am. Chem. Soc, 136, 16326, 10.1021/ja508721y Xia, 2019, Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application, Acta Pharm. Sin. B, 9, 675, 10.1016/j.apsb.2019.01.011 Ben-Akiva, 2020, Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal, Sci. Adv, 6, 10.1126/sciadv.aay9035 Alibolandi, 2018, Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma, Int. J. Pharm., 549, 67, 10.1016/j.ijpharm.2018.07.052 Alibolandi, 2015, In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer, J. Contr. Release, 209, 88, 10.1016/j.jconrel.2015.04.026 Alibolandi, 2015, Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro, Int. J. Pharm., 479, 241, 10.1016/j.ijpharm.2014.12.035 Taghavi, 2017, Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery, Cancer Lett, 400, 1, 10.1016/j.canlet.2017.04.008 Alibolandi, 2017, Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation, J. Contr. Release, 264, 228, 10.1016/j.jconrel.2017.08.030 Zahiri, 2021 Yu, 2012, In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics, J. Contr. Release, 163, 46, 10.1016/j.jconrel.2012.05.046